BioNTech SE (BNTX) Times Interest Earned (2018 - 2025)
BioNTech SE (BNTX) posted Times Interest Earned of $76.86 for Q4 2025, up 4029.64% on a QoQ basis from $1.86 in Q3 2025, and up 751.68% year-over-year from $9.02 in Q4 2024.
BioNTech SE (BNTX) has 8 years of Times Interest Earned data on file, last reported at $76.86 in Q4 2025.
- In Q4 2025, Times Interest Earned rose 751.68% year-over-year to $76.86; the TTM figure through Dec 2025 stood at $20.01 (down 50.41% YoY), while the FY2025 annual figure was $20.13, down 58.04% from the prior year.
- Times Interest Earned advanced to $76.86 in Q4 2025, from $1.86 in the prior quarter.
- Across five years, Times Interest Earned topped out at $37.2 million in Q1 2021 and bottomed at -$2238.0 in Q4 2021.
- A 5-year average of $1.9 million and a median of -$16.25 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned jumped 6270872.74% — and 2022, when it tumbled 1496.13%.
- Year by year, Times Interest Earned stood at -$2238.0 in 2021, then jumped by 99.08% to -$20.7 in 2022, then retreated by 0.89% to -$20.88 in 2023, then surged by 43.52% to -$11.79 in 2024, then jumped by 751.68% to $76.86 in 2025.
- The last three Times Interest Earned figures came in at $76.86 (Q4 2025), $1.86 (Q3 2025), and $71.59 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 76.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.86 |
| Sep 30, 2025 | 1.86 |
| Jun 30, 2025 | 71.59 |
| Mar 31, 2025 | 15.76 |
| Dec 31, 2024 | -11.79 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | 132.36 |
| Mar 31, 2024 | 107.91 |
| Dec 31, 2023 | -20.88 |
| Sep 30, 2023 | -36.55 |
| Jun 30, 2023 | 433.31 |
| Mar 31, 2023 | -22.57 |
| Dec 31, 2022 | -20.70 |
| Sep 30, 2022 | -555.23 |
| Jun 30, 2022 | -380.97 |
| Mar 31, 2022 | -709.36 |
| Dec 31, 2021 | -2,237.95 |
| Sep 30, 2021 | -57.12 |
| Jun 30, 2021 | -23.87 |
| Mar 31, 2021 | 37.19 Mn |
| Dec 31, 2020 | 17,955.88 Bn |
| Mar 31, 2020 | 593.00 |
| Dec 31, 2019 | -138.86 |
| Sep 30, 2019 | -449.68 |
| Dec 31, 2018 | 4.50 |
| Sep 30, 2018 | 0.00 |